SCHEMBL4285918

SCHEMBL4285918

CCCCCN1C(=O)NC(=O)CC1(N)N

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.38
CYP19A1 P11511 6/20 0.36
PTGS1 P23219 3/20 0.34
PTGS2 P35354 3/20 0.34
MGLL Q99685 3/20 0.34
FAAH O00519 2/20 0.34
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CRBN Q96SW2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4297245 0.95 CYP19A1 (0.35) ALOX5CYP19A1KDM4ELMNACYP2C19
SCHEMBL4284253 0.71 PTGS1 (0.37) PTGS1KDM4ELMNACYP2C19ALDH1A1
SCHEMBL5597442 0.69 CRBN (0.41) KDM4ELMNACYP2C19TSHRNPSR1
SCHEMBL11499230 0.68 ALOX5 (0.47) ALOX5PTGS1PTGS2MGLLFAAH
SCHEMBL26289325 0.67 MGLL (0.38) ALOX5PTGS1PTGS2MGLLFAAH
SCHEMBL461664 0.67 CRBN (0.45) ALOX5PTGS1PTGS2MGLLFAAH
SCHEMBL26459349 0.67 ALOX5 (0.50) ALOX5PTGS1PTGS2MGLLFAAH
Succinimide SCHEMBL7039031 0.66 CRBN (0.61) ALOX5CYP19A1KDM4ELMNACYP2C19
Succinimide SCHEMBL27423831 0.66 CRBN (0.61) ALOX5CYP19A1KDM4ELMNACYP2C19
SCHEMBL6228568 0.66 ALOX5 (0.45) ALOX5PTGS1PTGS2MGLLFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009157938-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER CV THERAPEUTICS, INC. (US) 2009-12-30 WO disclosed